1. Construction of Prognostic ceRNA Network Landscape in Breast Cancer to Explore Impacting Genes on Drug Response by Integrative Bioinformatics Analysis
   Mahboubeh Sadeghi et al, 2024, Letters in Drug Design & Discovery CrossRef
2. Risk prediction in cutaneous melanoma patients from their clinico-pathological features: superiority of clinical data over gene expression data
   Chakit Arora et al, 2020, Heliyon CrossRef
3. Contrast-Enhanced Ultrasonography in the Diagnosis and Treatment Modulation of Breast Cancer
   Ioana Boca (Bene) et al, 2021, Journal of Personalized Medicine CrossRef
4. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer
   Pratibha Pandey et al, 2023, Biomedicine & Pharmacotherapy CrossRef
5. Partial response to trastuzumab deruxtecan (DS8201) following progression in HER2-amplified breast cancer with pulmonary metastases managed with disitamab vedotin (RC48): a comprehensive case report and literature review
   Yanfang Lan et al, 2024, Frontiers in Oncology CrossRef
6. Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer
   Xiao Chu et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
7. LINC01857 as an oncogene regulates CREB1 activation by interacting with CREBBP in breast cancer
   Youyi Xiong et al, 2019, Journal of Cellular Physiology CrossRef
8. The overexpression of DNA repair genes in invasive ductal and lobular breast carcinomas: Insights on individual variations and precision medicine
   Ruwaa I. Mohamed et al, 2021, PLOS ONE CrossRef
9. Rational Approach to Finding Genes Encoding Molecular Biomarkers: Focus on Breast Cancer
   Nathalie Schneider et al, 2022, Genes CrossRef
10. The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis
    Tian Tian et al, 2018, Molecular Therapy - Nucleic Acids CrossRef
11. MiRNAs: A New Approach to Predict and Overcome Resistance to Anticancer Drugs
    Noor Altaleb, 2020, Clinical Cancer Drugs CrossRef
12. Quantitative Histopathology of Stained Tissues using Color Spatial Light Interference Microscopy (cSLIM)
    Hassaan Majeed et al, 2019, Scientific Reports CrossRef
13. New label-free ultrasensitive electrochemical immunosensor-based Au/MoS2/rGO nanocomposites for CA 27-29 breast cancer antigen detection
    Nawal A. Alarfaj et al, 2018, New Journal of Chemistry CrossRef
14. Prognostic significance of fatty acid binding protein‐4 in the invasive ductal carcinoma of the breast
    Yinji Cui et al, 2019, Pathology International CrossRef
15. Is there any relationship between adc values of diffusion-weighted imaging and the histopathological prognostic factors of invasive ductal carcinoma?
    Hale Aydin et al, 2018, The British Journal of Radiology CrossRef
16. PAX2 promoter methylation and AIB1 overexpression promote tamoxifen resistance in breast carcinoma patients
    Rosa Jahangiri et al, 2022, Journal of Oncology Pharmacy Practice CrossRef
17. Discordance in ER, PR, HER2, and Ki-67 Expression Between Primary and Recurrent/Metastatic Lesions in Patients with Primary Early Stage Breast Cancer and the Clinical Significance: Retrospective Analysis of 75 Cases
    Li Peng et al, 2021, Pathology and Oncology Research CrossRef